As expected, either mRNA level or protein level of Bdh1 was obviously reduced by PA treatment in LO2 cells (Fig. 1D, E), indicating that the hyperlipidemia-induced Bdh1 deficiency might contribute to the pathogenesis of MAFLD. Here, BDH1 is linked to hyperlipidemia.